Paid and Unpaid Productivity Losses Due to Premature Mortality from Cancer in the European Union in 2018

Ortega Ortega, Marta, Hanly, Paul, Pearce, Alison, Soerjomataram, Isabelle and Sharp, Linda (2021) Paid and Unpaid Productivity Losses Due to Premature Mortality from Cancer in the European Union in 2018. In: iHEA 2021 World Congress, 12-15 July 2021, online. (Submitted)

Full text not available from this repository.

Abstract

Purpose: When someone dies prematurely from cancer this represents a loss of productivity for society. This loss can be valued and provides a measure of the cancer burden. We estimated paid and unpaid productivity lost due to cancer-related premature mortality in Europe in 2018.

Methods: Lost productivity was estimated for all cancers combined and 23 cancer sites by countries in Europe adn for all Europe as a whole. Deaths aged 15-64 by cancer site, age, sex and country were abstracted from GLOBOCAN 2018. Unpaid time lost was derived from Eurostat. Paid and unpaid (housework, caring, volunteering) productivity losses were valued using the Human Capital Approach, making adjustments for labour force participation and unemployment. Costs are in €2018.

Results: 347,149 premature cancer deaths occurred (60% male) in Europe in 2018. The total value of productivity lost due to cancer was €104.6 billion. 50.6% was accounted for by lost paid work, 20.9% was due to unpaid work undertaken by employed people and 28.5% unpaid work by non-employed people. Females accounted for 36.6% of the paid work losses but half (48.9%) of the unpaid work losses. Losses were highest in Western Europe (€52.0 billion). The most costly cancer was lung (€21.7 billion), followed by breast (€10.7 billion). The average cost/death for paid work was €152,398, with. Hodgkin lymphoma the most costly cancer (€293,385) and uterine the least costly (€79,187). The average cost/death for unpaid work among the employed was €63,137, and for the non-employed was €85,692.

Conclusions: The value of lost productivity due to cancer is significant and almost half is due to unpaid work losses. This highlights the importance of considering both paid and unpaid work when assessing the economic burden of a disease to inform strategic policy decision-making.

Item Type:	Conference or Workshop Item (Paper)
Additional Information:	Paper published in International Journal of Cancer, 150 (4). pp. 580-593. ISSN 1097-0215. Separate NORMA record: http://norma.ncirl.ie/5055/
Subjects:	D History General and Old World > D History (General) > D901 Europe (General) Q Science > Life sciences > Medical sciences > Pathology > Tumors > Cancer J Political Science > JN Political institutions (Europe) > European Union H Social Sciences > Economics > Microeconomics > Production (Economic theory) > Industrial productivity > Labor productivity
Divisions:	School of Business > Staff Research and Publications
Depositing User:	Clara Chan
Date Deposited:	23 Mar 2022 12:50
Last Modified:	23 Mar 2022 12:50
URI:	https://norma.ncirl.ie/id/eprint/5563

Actions (login required)

View Item